GlassScriptPhysician profile
Kristen A Clancy
NPI 1942443668
$9,521.92
in general payments reported to CMS, 2019-2025
36 companies · $2,047 in 2025
The $2,047 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,516 · 2022: $1,920 · 2023: $2,020 · 2024: $2,020 · 2025: $2,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,087.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,086.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,636.06 | 2021-2025 | Repatha, Repatha |
| Pfizer INC. | $1,018.63 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $834.68 | 2021-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $802.02 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $577.84 | 2021-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $473.27 | 2021-2025 | Verquvo, Winrevair |
| Actelion Pharmaceuticals US, INC. | $468.90 | 2022-2025 | Uptravi, Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $455.03 | 2021-2025 | Lifevest |
| Edwards Lifesciences Corporation | $328.59 | 2022-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Bayer Healthcare Pharmaceuticals INC. | $286.30 | 2021-2025 | |
| Cvrx, INC. | $283.63 | 2024-2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $277.01 | 2021-2024 | Xarelto |
| Abbott Laboratories | $266.12 | 2021-2022 | |
| Boston Scientific Corporation | $190.56 | 2023-2025 | Watchman Flx, Watchman Access System |
| Kiniksa Pharmaceuticals International, Plc | $188.63 | 2024 | Arcalyst |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristen Clancy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.